General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent

Drug and Chemical Toxicology

Volumn 33, Issue 1, 2010, Pages 88-96

  Zhao, Li ^a   Zhen, Chen ^a   Wu, Zhaoqiu ^b   Hu, Rong ^a   Zhou, Changlin ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Analgesic; Developmental toxicity; Gambogic acid; General pharmacology

Indexed keywords

ACETIC ACID; ANTINEOPLASTIC AGENT; GAMBOGIC ACID;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BODY WEIGHT; BONE DEVELOPMENT; BREATHING RATE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FETUS; FETUS DEVELOPMENT; HEART RATE; LIVE BIRTH; LOCOMOTION; MEAN ARTERIAL PRESSURE; MOTOR COORDINATION; MOUSE; NONHUMAN; PAIN; RAT; RESPIRATORY SYSTEM; SLEEP TIME; WRITHING TEST;

ABNORMALITIES, DRUG-INDUCED; ANALGESICS; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; DOGS; EATING; FEMALE; FETAL DEVELOPMENT; MICE; ORGAN SIZE; XANTHONES;

CANIS FAMILIARIS; MUS; RATTUS;

EID: 72949086591     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480540903173534     Document Type: Article

References (31)

1. Amagaya, S., Iizuka, A., Makino, B., Kubo, M., Komatsu, Y., Cheng, F. C., et al. (2001). General pharmacological properties of Sho-seiryu-to (TJ-19) extracts. Phytomedicine 8:338-347.
2. Asano, J., Chiba, K., Tada, M., Yoshii, T. (1996). Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry 41:815-820.
3. Carpiniello, B., Baita, A., Carta, M. G., Sitzia, R., Macciardi, A. M., Murgia, S., et al. (2002). Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study. Eur Psychiatry 17:394-398.
4. Deraedt, R., Jouquey, S., Delevallee, F., Flahaut, M. (1980). Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 61:17-24.
5. Dubuisson, D., Dennis, S. G. (1977). The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4:161-174.
6. Gu, H., You, Q., Liu, W., Yang, Y., Zhao, L., Qi, Q., et al. (2008). Gambogic acid-induced tumor cell apoptosis by T-lymphocyte activation in H22 transplanted mice. Int Immunopharmacol 8:1493-1502.
7. Guo, Q., Qi, Q., You, Q., Gu, H., Zhao, L., Wu, Z. (2006a). Toxicological studies of gambogic acid and its potential targets in experimental animals. Basic Clin Pharmacol Toxicol 99:178-184.
8. Guo, Q. L., Zhao, L., You, Q. D., Wu, ZQ, Gu, H. Y. (2004b). Gambogic acid inducing apoptosis in human gastric adenocarcinoma SGC-7901 cells. Chin J Nat Med 2:106-110.
9. Guo, Q. L., Lin, S. S., You, Q. D., Gu, H. Y., Yu, J., Zhao, L., et al. (2006b). Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 78:1238-1245. (Pubitemid 43179978)
10. Guo, Q. L., You, Q. D., Wu, Z. Q., Yuan, S. T., Zhao, L. (2004a). General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin 25:769-774.
11. Inoue, K., Motonaga, A., Nishimura, T., Yokota, M., Miki, N., Fujisawa, H., et al. (1991). Mechanism of anti-inflammatory action of etodolac. Arzneimittelforschung 41:235-239.
12. Lin, L. J., Lin, L. Z., Pezzuto, J. M., Cordell, G. A., Ruangrungsi, N. (1993). Isogambogic acid and isomorellinol from Garcinia hanburyi. Magn Reson Chem 31:340-347.
13. Muller, J. C., Botelho, G. G., Bufalo, A. C., Boareto, A. C., Rattmann, Y. D., Martins, E. S., et al. (2009). Morinda citrifolia Linn (Noni): in vivo and in vitro reproductive toxicology. J Ethnopharmacol 121:229-233. Epub 2008 Oct 30.
14. Ollis, W. D., Ramsay, M. V. J., Sutherland, I. O., Mongkolsuk, S. (1965). Constitution of gambogic acid. Tetrahedron 21:1453-1470.
15. Ortiz-Sanchez, E., Daniels, T. R., Helguera, G., Martinez-Maza, O., Bonavida, B., Penichet, M. L. (2009). Enhanced cytotoxicity of an antitransferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia 23:59-70. Epub 2008 Oct 23.
16. Qi, Q., Gu, H., Yang, Y., Lu, N., Zhao, J., Liu, W., et al. (2008a). Involvement of matrix metalloproteinases 2 and 9 in gambogic acid-induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J Mol Med 86:1367-1377.
17. Qi, Q., Lu, N., Wang, X. T., Gu, H. Y., Yang, Y., Liu, W., et al. (2008b). Anti-invasive effect of gambogic acid in MDAMB- 231 human breast carcinoma cells. Biochem Cell Biol 86:386-395.
18. Qi, Q., You, Q., Gu, H., Zhao, L., Liu, W., Lu, N., et al. (2008c). Studies on the toxicity of gambogic acid in rats. J Ethnopharmacol 117:433-438.
19. Qiang, L., Yang, Y., You, Q. D., Ma, Y. J., Yang, L., Nie, F. F., et al. (2008). Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem Pharmacol 75:1083-1092.
20. Rosland, J. H., Tjolsen, A., Maehle, B., Hole, K. (1990). The formalin test in mice: effect of formalin concentration. Pain 42:235-242.
21. Staples, R. E., Schnell, V. L. (1964). Refinements in rapid clearing technic in the KOH-alizarin red S method for fetal bone. Stain Technol 39:61-63.
22. Weakley, T. J. R., Cai S-X., Zhang, H-Z., Keana, J. F. W. (2002). Crystal structure of the pyridine salt of gambogic acid. J Chem Crystallogr 31:501-505.
23. Wilson, J. G. (1965). Embryological considerations in teratology. Ann N Y Acad Sci 123:219-227.
24. Wu, Z. Q., Guo, Q. L., You, Q. D., Zhao, L., Gu, H. Y. (2004). Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull 27:1769-1774.
25. Yamauchi, H., Nishimura, K., Nakata, K., Suda, H., Iso, T., Shimizu, M., et al. (1987). General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril. Arzneimittelforschung 37(2):157-164.
26. Yang, Y., Yang, L., You, Q. D., Nie, F. F., Gu, H. Y., Zhao, L., et al. (2007). Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett 256:259-266.
27. Yi, T., Yi, Z., Cho, S. G., Luo, J., Pandey, M. K., Aggarwal, B. B., et al. (2008). Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 68(6):1843-1850.
28. Yongna, Z., Wantana, R., Pisit, B., Zhongkun, L., Rongping, Z. (2005). Analgesic and antipyretic activities of the aqueous extract of Urtica macrorrhiza in experimental animals. Fitoterapia 76:91-95.
29. Zhai, D., Jin, C., Shiau, C. W., Kitada, S., Satterthwait, A. C., Reed, J. C. (2008). Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins. Mol Cancer Ther 7:1639-1646.
30. Zhao, J., Qi, Q., Yang, Y., Gu, H. Y., Lu, N., Liu, W., et al. (2008). Inhibition of alpha(4) integrin-mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. Eur J Pharmacol 589(1-3):127-131.
31. Zhao, L., Guo, Q. L., You, Q. D., Wu, Z. Q., Gu, H. Y. (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC- 803 cells. Biol Pharm Bull 27:998-1003.